• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

SPAC

Hearing loss tech developer Envoy goes public in SPAC deal

October 4, 2023 By Sean Whooley

Anzu Special Acquisition Corp. and Envoy Medical announced last week that they completed a previously announced business combination. The combination with Anzu, a special purpose acquisition company (SPAC) results in Envoy becoming a publicly listed company. It continues to operate under the name Envoy Medical. The company’s common stock commenced trading on the Nasdaq market […]

Filed Under: Business/Financial News, Featured, Implants, Mergers & Acquisitions, News Well, Otolaryngology/Ear, Nose & Throat (ENT), Wall Street Beat Tagged With: Envoy Medical Corp., SPAC

Sanuwave to go public in $127.5M SPAC merger

August 24, 2023 By Sean Whooley

Wound care company Sanuwave Health announced that it entered into a business combination agreement with SEP Acquisition Corp. The merger with SEP, a special purpose acquisition company (SPAC), aims to create a Nasdaq-listed company. Upon the transaction’s completion, the combined company expects to operate under the Sanuwave name and the “SNWV” ticker. The proposed transaction […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, News Well, Wall Street Beat, Wound Care Tagged With: Sanuwave, SANUWAVE Health Inc., SPAC

Weight loss balloon maker Allurion goes public on NYSE through SPAC merger

August 3, 2023 By Sean Whooley

Allurion Technologies announced that it completed a SPAC merger and began trading on the New York Stock Exchange. Natick, Massachusetts-based Allurion went public on Aug. 2 under the ALUR ticker. The business combination took place with Compute Health Acquisition Corp, a special purpose acquisition company (SPAC). Allurion develops an artificial intelligence-powered weight loss program. Its program […]

Filed Under: Business/Financial News, Featured, Health Technology, Mergers & Acquisitions, News Well, Software / IT, Wall Street Beat, Weight loss Tagged With: Allurion Technologies, SPAC

How did medtech SPAC mergers fare?

May 3, 2023 By Sean Whooley

Over the past few years, special purpose acquisition corporations (SPACs) have found their way into the medtech space. These businesses — built to bring private companies public — raise initial public offerings (IPOs). They then go and acquire existing companies, taking them public in the process. The value of these mergers varies, but some in […]

Filed Under: Business/Financial News, Featured, In-Depth Coverage, MassDevice Earnings Roundup, News Well, Special Content, Wall Street Beat Tagged With: Accelus, Aerami Therapeutics, Better Therapeutics, Butterfly Network, HeartFlow, Hyperfine, Memic Innovative Surgery, Momentis Surgical, Pear Therapeutics, SPAC

The top 5 medtech news stories of 2021

December 29, 2021 By Chris Newmarker

The past year saw significant changes in the medtech space. Our editorial team picked their top stories. The lingering COVID-19 pandemic was top of mind in 2021, but there was much more going on in the medical device industry. The Life Sciences editorial team here at WTWH Media discussed their top picks during the December […]

Filed Under: Business/Financial News, Diabetes, Distribution, Featured, News Well, Surgical, Surgical Robotics Tagged With: Climate change, robot-assisted, Robotic Surgery, SPAC, Vicarious Surgical

Hyperfine closes SPAC merger, will begin trading on Nasdaq

December 22, 2021 By Sean Whooley

Hyperfine announced today that it completed its merger with HealthCor Catalio Acquisition Corp. and has gone public. Guilford, Connecticut-based Hyperfine initially announced the proposed merger with HealthCor, a special purpose acquisition company (SPAC) in July. The company will receive approximately $160 million in gross cash proceeds from the business combination and a concurrent private placement, […]

Filed Under: Business/Financial News, Featured, Imaging, Mergers & Acquisitions, Wall Street Beat Tagged With: HealthCor Catalio Acquisition Corp., Hyperfine, SPAC

LumiraDx goes public as SPAC deal closes

September 29, 2021 By Chris Newmarker

LumiraDx shares are trading at more than $8 apiece on the Nasdaq today under the symbol LMDX after the company completed its merger with a SPAC called CA Healthcare Acquisition Corp. The point of care diagnostic testing company has a pipeline of more than 30 assays across common health conditions, including infectious diseases, cardiovascular diseases, […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: LumiraDX, SPAC, SPACs

Prenetics is going public through a SPAC deal

September 16, 2021 By Sean Whooley

Genomic and diagnostic testing company Prenetics announced that it will merge with Artisan Acquisition Corp. and go public. Artisan, a special purpose acquisition company (SPAC), will provide a business portfolio across retail, hospitality, healthcare, property and other strategic businesses for Prenetics to substantially expand its platform through the merger, according to a news release. The […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions, Wall Street Beat Tagged With: Artisan Acquisition Corp., coronavirus, COVID-19, Prenetics, SPAC, SPACs

Fresenius Medical Care investing $25M in Humacyte as it goes public in SPAC deal

August 30, 2021 By Sean Whooley

Fresenius Medical Care announced today that it will invest $25 million in Humacyte in connection with the merger of Humacyte and a SPAC. Humacyte, which develops implantable human acellular vessels for multiple vascular repair, reconstruction and replacement, entered into a merger with a special purpose acquisition company (SPAC), leading Fresenius to increase its position in […]

Filed Under: Business/Financial News, Dialysis, Featured, Mergers & Acquisitions Tagged With: Fresenius, Fresenius Medical Care, Humacyte, SPAC

HeartFlow to go public in $2.8B SPAC merger

July 15, 2021 By Danielle Kirsh

HeartFlow today said that it will go public by merging with a SPAC called Longview Acquisition Corp. The merger is valued at $2.4 billion plus an estimated $400 million in cash after closing. The transaction is expected to deliver up to $599 million of gross proceeds to HeartFlow to accelerate the growth of its noninvasive, […]

Filed Under: Big Data, Business/Financial News, Cardiovascular, Featured, Funding Roundup, Health Technology, Initial Public Offering (IPO), Software / IT Tagged With: HeartFlow, Longview Acquisition Corp., SPAC

Hyperfine, Liminal to go public in $580M SPAC deal

July 8, 2021 By Danielle Kirsh

Hyperfine and Liminal Sciences today said they will go public by merging with a SPAC called HealthCor Catalio Acquisition Corp. The merger is valued at approximately $580 million upon closing and is expected to have a combined entity of $375 million in cash. The combined company’s estimated cash balance will be $207 million from the […]

Filed Under: Business/Financial News, Featured, Imaging Tagged With: HealthCor Catalio Acquisition Corp., Hyperfine, Liminal, SPAC

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy